Greenwich LifeSciences, Inc. - 10-Q Filing
Greenwich LifeSciences filed its Q1 2026 Form 10-Q reporting a net loss of $5.66 million for the three months ended March 31, 2026, compared to a net loss of $2.74 million in the same period last year. The company had cash of $10.5 million as of March 31, 2026, up from $6.18 million at December 31, 2025, primarily due to $9.03 million raised through an ATM program during the quarter.
Tickers: $GLSI